Submission for OMB Review; 30-Day Comment Request Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIH), 53112-53113 [2024-13914]
Download as PDF
<![CDATA[
53112
Federal Register / Vol. 89, No. 122 / Tuesday, June 25, 2024 / Notices
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Dated: June 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13838 Filed 6–24–24; 8:45 am]
Maria G. Button,
Director, Executive Secretariat.
BILLING CODE 4140–01–P
[FR Doc. 2024–13857 Filed 6–24–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Fishers Lane, Room 3G21A, Rockville, MD
20852, 240.627.3219, shiv.prasad@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: July 18, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G21A,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
VerDate Sep<11>2014
17:03 Jun 24, 2024
Jkt 262001
Submission for OMB Review; 30-Day
Comment Request Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
(NIH)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Mikia Currie,
Project Clearance Officer, Office of
Policy for Extramural Research
Administration, 6705 Rockledge Drive,
Suite 350, Bethesda, Maryland 20892 or
call non-toll-free number (301) 435–
ADDRESSES:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
0941 or email your request, including
your address to: curriem@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 10th, 2024 (89 FR
25275) and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
The National Institutes of Health
(NIH) may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
Office of Management and Budget
(OMB) control number.
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery, EXTENSION, 0925–0648,
expiration date 06/30/2024, National
Institutes of Health (NIH).
Need and Use of Information
Collection: There are no substantive
changes being requested for this
submission. The information collection
activity will garner qualitative customer
and stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. This generic
clearance will continue to provide
information about the NIH Institutes
and Centers customer or stakeholder
perceptions, experiences, and
expectations, provide an early warning
of issues with service, or focus attention
on areas where communication,
training, or changes in operations might
improve delivery of products or
services. It will also allow feedback to
contribute directly to the improvement
of program management. Feedback
collected under this generic clearance
will provide useful information, but it
will not yield data that can be
generalized to the overall population.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
103,083.
E:\FR\FM\25JNN1.SGM
25JNN1
53113
Federal Register / Vol. 89, No. 122 / Tuesday, June 25, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of collection
Average time
per response
(in hours)
Total annual
burden hours
Customer Satisfaction Surveys .......................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Focus Groups ..................................................................................................
Usability and Pilot Testing ...............................................................................
Conference/Training—Pre-and Post-Surveys ..................................................
NIH-Wide Basic Abstract Form ........................................................................
NIH-Wide Basic Registration Form ..................................................................
1,000
1,000
1,000
150,000
100,000
50,000
75,000
1
1
1
1
2
1
1
30/60
90/60
90/60
5/60
10/60
1
3/60
500
1,500
1,500
12,500
33,333
50,000
3,750
Total ..........................................................................................................
378,000
478,000
........................
103,083
Dated: June 17, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–13914 Filed 6–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel; Review
of AREA grants in Cell Biology,
Molecular Biology and Genetics, July
08, 2024, 09:00 a.m. to July 09, 2024,
07:00 p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, which was
published in the Federal Register on
June 07, 2024, 89 FR 48659, Doc 2024–
12475.
This meeting is being amended to
change the meeting from a two-day
meeting to a one-day meeting on July 8,
2024, from 9:00 a.m. to 7:00 p.m. The
meeting is closed to the public.
Dated: June 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13840 Filed 6–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Annual
frequency
per response
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
VerDate Sep<11>2014
17:03 Jun 24, 2024
Jkt 262001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Social and Community Influences
Across the Lifecourse.
Date: July 15–16, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Hybrid Meeting).
Contact Person: David E Pollio, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F,
Bethesda, MD 20892, (301) 594–4002,
polliode@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Microbial Diagnostics, Detection
and Decontamination.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–5997, shinako.takada@
nih.gov.
Name of Committee: Social and
Community Influences on Health Integrated
Review Group; Population and Public Health
Approaches to HIV/AIDS Study Section.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aubrey S Madkour, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000C,
Bethesda, MD 20892, (301) 594–6891,
madkouras@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA:
Understanding Neurological Effects of
COVID–19 and Post-Acute Sequelae of
SARS–CoV–2 Infection.
Date: July 17–18, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey Gregory
Kazantsev, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5201, Bethesda, MD 20892, (301) 435–
1042, aleksey.kazantsev@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer
Diagnostics and Treatments (CDT).
Date: July 17–18, 2024.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor A Panchenko,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 802B2,
Bethesda, MD 20892, (301) 867–5309,
victor.panchenko@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Clinical Care and Health
Interventions.
Date: July 17, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacinta Bronte-Tinkew,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
E:\FR\FM\25JNN1.SGM
25JNN1
]]>Agencies
[Federal Register Volume 89, Number 122 (Tuesday, June 25, 2024)]
[Notices]
[Pages 53112-53113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13914]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request Generic
Clearance for the Collection of Qualitative Feedback on Agency Service
Delivery (NIH)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Ms. Mikia Currie, Project Clearance Officer,
Office of Policy for Extramural Research Administration, 6705 Rockledge
Drive, Suite 350, Bethesda, Maryland 20892 or call non-toll-free number
(301) 435-0941 or email your request, including your address to:
[email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on April 10th, 2024 (89 FR
25275) and allowed 60 days for public comment. No public comments were
received. The purpose of this notice is to allow an additional 30 days
for public comment.
The National Institutes of Health (NIH) may not conduct or sponsor,
and the respondent is not required to respond to, an information
collection that has been extended, revised, or implemented on or after
October 1, 1995, unless it displays a currently valid Office of
Management and Budget (OMB) control number.
In compliance with section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, NIH has submitted to OMB a request for review and approval
of the information collection listed below.
Proposed Collection: Generic Clearance for the Collection of
Qualitative Feedback on Agency Service Delivery, EXTENSION, 0925-0648,
expiration date 06/30/2024, National Institutes of Health (NIH).
Need and Use of Information Collection: There are no substantive
changes being requested for this submission. The information collection
activity will garner qualitative customer and stakeholder feedback in
an efficient, timely manner, in accordance with the Administration's
commitment to improving service delivery. This generic clearance will
continue to provide information about the NIH Institutes and Centers
customer or stakeholder perceptions, experiences, and expectations,
provide an early warning of issues with service, or focus attention on
areas where communication, training, or changes in operations might
improve delivery of products or services. It will also allow feedback
to contribute directly to the improvement of program management.
Feedback collected under this generic clearance will provide useful
information, but it will not yield data that can be generalized to the
overall population.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 103,083.
[[Page 53113]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Annual Average time
Type of collection Number of frequency per per response Total annual
respondents response (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Customer Satisfaction Surveys................... 1,000 1 30/60 500
In-Depth Interviews (IDIs) or Small Discussion 1,000 1 90/60 1,500
Groups.........................................
Focus Groups.................................... 1,000 1 90/60 1,500
Usability and Pilot Testing..................... 150,000 1 5/60 12,500
Conference/Training--Pre-and Post-Surveys....... 100,000 2 10/60 33,333
NIH-Wide Basic Abstract Form.................... 50,000 1 1 50,000
NIH-Wide Basic Registration Form................ 75,000 1 3/60 3,750
---------------------------------------------------------------
Total....................................... 378,000 478,000 .............. 103,083
----------------------------------------------------------------------------------------------------------------
Dated: June 17, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2024-13914 Filed 6-24-24; 8:45 am]
BILLING CODE 4140-01-P
